US inflation increased by 0.4% from September to October 2026, slightly above expectations but showing a slowdown in price rises as gas prices fell during the month. Despite the dip, gas prices remain over $1 higher per gallon than a year ago, impacting consumer sentiment and political outcomes, notably contributing to Republican losses in the midterm elections. The Federal Reserve raised interest rates in September to curb inflation, with another hike expected in December, though energy costs linked to the Iran war continue to drive inflation above the Fed's 2% target. Consumer sentiment improved slightly with easing gas prices, but concerns over an AI investment bubble and stock market volatility persist.
US inflation changes in October 2026 provide context for market conditions. For readers following US stocks, here is Pluang's market snapshot as of Nov 10, 2026 20:21 WIB: out of 150 priced US stocks, 52 rose and 94 fell. Notable movers include NEM at USD 121.11 with a 1-day change of -3.24%, AMAT at USD 359.02 down 3.11%, and LI at USD 12.72 up 3.08%. Typical hold times range from 60 to 104 days, with varied Pluang order activity percentages.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
